Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 3NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Brain Neoplasms 5Squamous Cell Carcinoma of Head and Neck 3Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Oropharyngeal Neoplasms 2Mouth Neoplasms 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Gliosarcoma 2Glioblastoma 2Colorectal Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma 2Breast Neoplasms 2Urogenital Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Rare Diseases 1Pancreatic Neoplasms 1Oligodendroglioma 1Meningioma 1Melanoma 1Lung Neoplasms 1Head and Neck Neoplasms 1Glioma 1Genetic Diseases, Inborn 1Carcinoma, Renal Cell 1Carcinoma, Merkel Cell 1

Interventions

Cetuximab 7Magnetic Resonance Spectroscopy 5Radiotherapy 4Erlotinib Hydrochloride 4Cisplatin 4Bevacizumab 4Trastuzumab 3Specimen Handling 3Radiotherapy, Conformal 3Carboplatin 3sargramostim 2ixabepilone 2Vorinostat 2Sorafenib 2SS1(dsFv)PE38 2Radiotherapy, Intensity-Modulated 2Radiosurgery 2Paclitaxel 2N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2Lapatinib 2Fluorouracil 2Fluorodeoxyglucose F18 2Docetaxel 2Dasatinib 2Chemotherapy, Adjuvant 2Biopsy 2trastuzumab deruxtecan 1tipifarnib 1temsirolimus 1temoporfin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Salivary Gland Neoplasms × Radiosurgery × Clear all
NCT04576091 2024-12-13

Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer

National Cancer Institute (NCI)

Phase 1 Active not recruiting
7 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Salivary Gland Neoplasms

NCT00738868 2011-05-13

Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery

National Cancer Institute (NCI)

Phase 2 Completed
45 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡